Clinical predictors of survival in real world practice in stage IV melanoma.
Hsien-Pang HuChristine ArcherDesmond YipGeoffrey PetersPublished in: Cancer reports (Hoboken, N.J.) (2022)
Most clinical factors investigated in this study were found to have a statistically significant impact on survival, with AJCC (8th edition) staging M1a-M1d, NLR (cutoff score 3), LDH, and brain metastases identified as independent prognostic factors in stage IV melanoma from a contemporary cohort treated with targeted therapies and immunotherapies.